StockTipsArenaBeta

BUY Alkem Laboratories Limited — Amit Shreeram Goel

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byAmit Shreeram GoelHorizon: Swing (≤2wk)9 Nov 2026via NDTV Profit (Live)

Entry₹5,375Inferred
Target₹5,730
Total upside +6.60%
Stop loss₹5,090-5.30% risk
CMP₹5,1141d ago
Active-4.86%+12.05%upside left 8d left
Follow Amit Shreeram Goel for new calls(25% target hit, 52 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 2 other Swing calls on ALKEMSee 281 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:31 am IST
5 supporting3 neutral2 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Alkem Laboratories reported consolidated revenue from operations of Rs 45,519.9 million and a profit for the period of Rs 6,671.3 million for the quarter ended September 30, 2026.

BSE · Board Meeting·12 Nov · 2d ago

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·9 Nov · 5d ago

Alkem Laboratories has appointed Dr. Amrut Naik as the new Chief Executive Officer (CEO) and Key Managerial Personnel.

BSE · Company Update·3 Nov · 2w ago

(opens in new tab)

The US FDA concluded an inspection of Alkem Laboratories' API manufacturing facility in Mandva with no Form 483 observations.

BSE · Company Update·30 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (3)

The company has appointed Mr. Gopal Kothari as the new CFO and KMP effective December 2, 2026.

BSE · Company Update·12 Nov · 2d ago

(opens in new tab)

Alkem Laboratories Limited has appointed Mr. Gopal Kothari as the new Chief Financial Officer, effective December 02, 2026.

NSE · Appointment·12 Nov · 2d ago

(opens in new tab)

Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·12 Nov · 2d ago

(opens in new tab)
Weighs against the BUY call (2)

Past week's volume 2.2× the 30-day average

Technicals · volume·13 Nov · yesterday

Alkem Laboratories Q2 Results: Net Profit Falls 12% To Rs 675 Crore; Ropes In Gopal Kothari As CFO

NewsNdtv-Profit·12 Nov · 2d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from Amit Shreeram Goel

Every call and its outcome